The recent FDA approval of a new oral treatment for patients with amyotrophic lateral sclerosis (ALS) adds another option for individuals who are diagnosed with the non-curable disease.
The American College of Rheumatology provided a summary of its updated guidelines, which include newly approved medications and recommendations for treating glucocorticoid-induced osteoporosis.
In this Q&A, Abdulrahman Alsuhibani, PharmD, discusses the results of his latest study examining the relationship between adverse events and the use of anti-obesity medications.
Biosimilars show promise in reducing costs and equaling efficacy, compared with originator compounds. But will they live up to that potential? Russell Cohen, MD, addressed these issues and more at the...
In her session, Millie Long, MD, reviewed the role of anticytokine therapy for treating Crohn disease and how new approaches to diagnosing, monitoring, and treating Crohn disease have helped advance the...
The approval comes after results from 2 phase 3 trials showed that the medication significantly reduced the amount of heavy bleeding compared with placebo.
